Cathy Hoath Merck

Ms. Hoath has been with Merck & Co., Inc. since she joined the Bio-Sterile Validation department in 1996, where she was responsible for process performance qualification of formulation and filling for sterile pharmaceutical products and vaccines. After spending several years supporting process qualification efforts, she moved into regulatory affairs leading CMC activities for pharmaceuticals, biologics and vaccines. Today, Ms. Hoath manages a global regulatory group that is primarily responsible for developing innovative regulatory strategies for vaccines in low and middle income countries. She holds a B.S. degree in Biology from Ursinus College.